Ms. Runlin Tian graduated from Xi’an Jiaotong-Liverpool University (XJTLU), Suzhou, China, with B.S. in Biological Sciences in 2022. Her undergraduate research focused on developing reliable cell models of Alzheimer's disease (AD). During her professional practice at Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, China, she carried out a project independently to screen the potential causative genes of sporadic AD and found some interesting clues, as well as the deficiencies and limitations of human induced pluripotent stem cell-based-neuron as an AD cell model. She then began working on building a brain organoid model of AD. She refined an entire stem cell culture system at XJTLU and stably maintained the H9 cell line for 10 generations with high pluripotency. Her aspirations extend beyond the laboratory, as she is resolute in her aim to contribute to the biopharmaceutical sector's research and development domain. With a vision to assume a managerial role, she is confident that the MSBHP program at Rice will equip her with the vital skills and knowledge needed to effectively address the dynamic challenges of the real world. In the pursuit of her goals, she remains steadfast in her dedication to scientific advancement and the pursuit of excellence, as she endeavors to make a meaningful impact on both the scientific community and the biopharmaceutical industry.